Barclays lowered the firm’s price target on Carter’s (CRI) to $22 from $25 and keeps an Underweight rating on the shares following the Q2 report. The firm remains cautious on the shares without more details on measures the company is taking to drive profitable traffic growth and asset productivity long-term.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRI: